Oh boy, so I said "Buy

Yellow Roadway

(YELL)

" -- then why has Bill Zollars, the CEO of Yellow, been so mad at me?

I said to sell

Chicago Mercantile

(CME) - Get Report

and then it went down huge. Then I was thoughtful enough to say it was OK below $200, and now I am hammered for doing so? What's wrong with this picture?

Of course, I am talking about the

New York Post's

look at how my television show has done, "Smart 'Money'? Cramer's bark worse than bite."

It's almost comical when the press tries to grade you. They tend not to have the resources to do a thorough job, and when they try, they often by nature just can't get it right.

Which is why I sent the

Post

the table I am giving you below. It shows how I really did in my first week of the show, and I have to tell you, it ain't that bad.

Of course, I was actually

negative

on Yellow, so negative that I managed to get the CEO calling in to the show to tell me that I was wrong. So far, so good. And the Chicago Merc? It was just a call that the stock was too high for the moment.

One of the things that makes it so difficult to grade the show is the emphasis. If I like something as a stock of the week, shouldn't that matter more than something I say in the Lightning Round? And if I change my view after the stock has gone down, and I say I now like it -- as I did with

GM

(GM) - Get Report

-- shouldn't that count

for

me, not against?

Whatever.

I thought you would enjoy the actuals, though, and you might conclude that my bite and my bark are both pretty effective.

Please note that due to factors including low market capitalization and/or insufficient public float, we consider several of the stocks mentioned below to be small-cap stocks. You should be aware that such stocks are subject to more risk than stocks of larger companies, including greater volatility, lower liquidity and less publicly available information, and that postings such as this one can have an effect on their stock prices.

At the time of publication, Cramer was long UnitedHealth, St. Joe, Cimarex, EnCana, Lucent, Yahoo!, Sears, J.P. Morgan, Altria, Halliburton, UnitedHealth Group and America Movil.

James J. Cramer is a director and co-founder of TheStreet.com. He contributes daily market commentary for TheStreet.com's sites and serves as an adviser to the company's CEO. Outside contributing columnists for TheStreet.com and RealMoney.com, including Cramer, may, from time to time, write about stocks in which they have a position. In such cases, appropriate disclosure is made. To see his personal portfolio and find out what trades Cramer will make before he makes them, sign up for

Action Alerts PLUS. While he cannot provide personalized investment advice or recommendations, he invites you to send comments on his column by

clicking here. Listen to Cramer's RealMoney Radio show on your computer; just click

here. Watch Cramer on "Mad Money" at 6 p.m. ET weeknights on CNBC. Click

here to order Cramer's latest book, "Real Money: Sane Investing in an Insane World," click

here to get his second book, "You Got Screwed!" and click

here to order Cramer's autobiography, "Confessions of a Street Addict."